Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H12N4O3 |
Molecular Weight | 236.2273 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H]1CC[C@@H](O1)N2C=NC3=C2N=CNC3=O
InChI
InChIKey=BXZVVICBKDXVGW-NKWVEPMBSA-N
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1
Molecular Formula | C10H12N4O3 |
Molecular Weight | 236.2273 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:34 UTC 2023
by
admin
on
Fri Dec 15 15:35:34 UTC 2023
|
Record UNII |
K3GDH6OH08
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000009947
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
WHO-VATC |
QJ05AF02
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
NCI_THESAURUS |
C97452
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
WHO-ATC |
J05AF02
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.4.2.1
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
29488
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
NDF-RT |
N0000175462
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
||
|
LIVERTOX |
NBK548326
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m4379
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB07104MIG
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
6548
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
135398739
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
DTXSID6022927
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
K3GDH6OH08
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
C431
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
DIDANOSINE
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
1191204
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
6664
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
Didanosine
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL1460
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
3364
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
K3GDH6OH08
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
100000087146
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
69655-05-6
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
D016049
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
869
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
4833
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
DIDANOSINE
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | Description: A white to almost white powder.Solubility: Sparingly soluble in water; slightly soluble in methanol R and ethanol (95 per cent) R.Category: Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor).Storage: Didanosine should be kept in a tightly closed container.Requirements: Didanosine contains not less than 98.5% and not more than 101.0% of C10H12N4O3, calculated with reference to the driedsubstance. | ||
|
612049
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
CC-20
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
490877
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY | |||
|
DB00900
Created by
admin on Fri Dec 15 15:35:34 UTC 2023 , Edited by admin on Fri Dec 15 15:35:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
In the chromatogram obtained with solution (2), the following peaks are eluted at the following relative retention with reference to didanosine (retention time about 13-15 min): impurity I about 1.4.
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|